Recent advances in the genomic and molecular characterization of PTCL, with enhanced understanding of pathobiology, have translated into significant...

Therefore, clinical management is often based on this limited literature and extrapolation of data from the more common, nodal T-cell lymphomas in...

The extranodal mature T-cell and NK-cell lymphomas and lymphoproliferative disorders represent a unique group of rare neoplasms with both overlapping...

There is insufficient evidence on the efficacy of psychological interventions for lymphoma patients. This review aimed to present the research...

Next generation sequencing (NGS) is a technology that broadens the horizon of knowledge of several somatic pathologies, especially in oncological and...

A development cohort including 70 AOSD and 37 lymphoma patients was used to establish a scoring model based on the features of PET/CT images

Synaptophysin is an immunohistochemical marker for neuroendocrine differentiation and is widely used in pathologic diagnosis. Its expression in...

This study confirms the hypothesis of lymphatic dissemination of HL in a contiguous mode, with additional links between more distant regions

Circulating tumor DNA (ctDNA) has offered a minimally invasive approach for the detection and measurement of cancer

Although FC diagnosis of CHL was historically considered unfeasible, our findings in a real-world clinical setting suggest that FC adds diagnostic...

T2w transverse sequences with fs yielded the highest detection rates and are well-suited for accurate whole-body PET/MRI in lymphoma patients

For NLPHL, pre-therapeutic FDG-PET scan is better than CeCT staging. FDG-PET has much better specificity for response assessment than CeCT